HJLI News and Press, Hancock Jaffe Laboratories Inc. From 12/10/20

VenoValve and CoreoGraft Primary Investigators to Present at Webinar IRVINE, CA / ACCESSWIRE / December 10 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that on Wednesday, December 1...

Patient Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the tenth VenoValve patient in HJLI's fi...

Hancock Jaffe Laboratories' (HJLI) board approved a reverse stock split of its shares of common stock at 1:25, effective Nov.30, 2020.The split would bring the company in compliance with Nasdaq listing requirements.Shares -12.5% PM For further details see: Hancock Jaffe a...

IRVINE, CA / ACCESSWIRE / November 27, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the company's Board of Directors has approved a reverse stock split of its shares of common stock at a...

Preliminary First-in-Human Study Results Published in Peer-Reviewed Journal IRVINE, CA / ACCESSWIRE / November 23 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Journal of Vas...

Meeting with FDA Set for December 22 IRVINE, CA / ACCESSWIRE / November 5, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Pre-IDE meeting with the U.S. Food and Drug Administratio...

First CoreoGraft Recipient Discharged from the Hospital IRVINE, CA / ACCESSWIRE / October 28, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the first heart bypass surgery in HJLI's f...

Requests Pre-IDE Meeting with FDA IRVINE, CA / ACCESSWIRE / October 27, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has submitted a Pre-IDE filing to the U.S. Food and Drug Admi...

3 Penny Stocks To Buy For Under $3 But Are They Worth The Risk? Are you looking for penny stocks to buy now ? What matters the most? Some traders think that price is the first thing to look at. I’m sure many would disagree with this but at the end of the day, we are talki...

Patient Continues to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / October 21, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the ninth VenoValve patient ...